Literature DB >> 1902626

Importance of viability and attachment to an ascites tumor in the release of plasminogen activator.

Q Dong1, M Zhou, V Subbarao, C Ts'ao.   

Abstract

Tumor plasminogen activator (PA) has been alleged to play a role in the growth and metastasis of tumors. Before such a role can be realized, PA first must be released from tumor cells. Having determined intra- and extracellular PA and PA-inhibitor activities in an experimental pancreatic ascites tumor grown in hamsters, the release of PA from these cells was investigated. No PA activity was detected in the suspension medium of freshly isolated tumor cells; inclusion of plasminogen, fibrinogen, or collagen in the medium yielded similar negative results. On the other hand, PA activity was demonstrated to be released in a time-dependent manner from these tumor cells embedded in fibrin clots. Plasminogen activator activity also was not found in the suspension medium of frozen-thawed tumor cells, despite the fact that most of them had breaks on their cell membrane. Unlike freshly isolated tumor cells, PA was not released from frozen-thawed cells embedded in fibrin clots. Full PA activity was demonstrated in frozen-thawed cells treated with Triton X-100, however. Frozen-thawed cells exhibited signs of severe damage, and more than 80% of them failed to exclude trypan blue. Obviously PA is released from viable tumor cells embedded in fibrin clots but not suspended in artificial medium. The PA-release mechanism, not PA itself, is destroyed in cells rendered nonviable by freeze thawing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902626      PMCID: PMC1886016     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

1.  The effect of peptides and monoclonal antibodies that bind to platelet glycoprotein IIb-IIIa complex on the development of clot tension.

Authors:  I Cohen; D L Burk; J G White
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

2.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

3.  Plasminogen activator release from cultured murine mast cells.

Authors:  J S Bartholomew; D E Woolley
Journal:  Biochem Biophys Res Commun       Date:  1988-06-16       Impact factor: 3.575

4.  Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.

Authors:  L A Erickson; M H Ginsberg; D J Loskutoff
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

5.  Cryptic and active plasminogen activators secreted by line 10 tumor cells in culture.

Authors:  N S Orenstein; A Buczynski; H F Dvorak
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

6.  Release of plasminogen activator from isolated perfused dog heart.

Authors:  F Matsubara; K Sueishi; Y Ishii; K Tanaka
Journal:  Thromb Haemost       Date:  1985-02-18       Impact factor: 5.249

7.  Directed migration of murine and human tumor cells to collagenases and other proteases.

Authors:  V P Terranova; D Maslow; G Markus
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

8.  Platelet interaction with a pancreatic ascites tumor.

Authors:  J Hamilton; V Subbarao; K Granack; C Ts'ao
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

9.  Cellular and extracellular plasminogen activator and inhibitor in an experimental tumour.

Authors:  Q Dong; M H Zhou; V Subbarao; C H Ts'ao
Journal:  Br J Exp Pathol       Date:  1988-10

Review 10.  Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.

Authors:  F Blasi; J D Vassalli; K Danø
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.